Skip to research content
Back to insiders

Boesen Biotech ApS

Follow this party across linked issuers and source filings.

PartySE · FISweden public disclosures

Companies in disclosed relationships

1

Public filings · 12 months

0

Net disclosed balance · 12 months

€0.00

Latest filing

8 May 2024

Signals are not available for this disclosure jurisdiction.

Recent filings

All disclosed operations, including compensation and transfers. Values can represent transferred assets rather than cash invested.

Recent public filings linked to this insider party
DateCompanyGross reported valueOpen
8 May 2024SynAct Pharma ABBuy

€159,994.40

Buy/sale net: €159,994.40
Open
25 Mar 2024SynAct Pharma ABMixed

SEK 1,384,029.60

Buy/sale net: SEK 98,325.00
Open
12 Sept 2023SynAct Pharma ABSell

SEK 2,775,385.40

Buy/sale net: -SEK 2,775,385.40
Open
17 Jan 2023SynAct Pharma ABBuy

SEK 2,060,604.20

Buy/sale net: SEK 2,060,604.20
Open
Buy

Gross reported value

€159,994.40

Evidence

SynAct Pharma AB

25 Mar 2024
Mixed

Gross reported value

SEK 1,384,029.60

Evidence

SynAct Pharma AB

12 Sept 2023
Sell

Gross reported value

SEK 2,775,385.40

Evidence

SynAct Pharma AB

17 Jan 2023
Buy

Gross reported value

SEK 2,060,604.20

Evidence

Network and companies

1 distinct company in the disclosed relationships. Network coverage is a separate preview.